⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Estrogen and HRT for Menopausal Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-05 — Vaginal estrogen: a potentially life-saving therapy: cross-connection with vaginal-estrogen: Local vaginal estrogen is positioned as a distinct, low-systemic-exposure counterpart to systemic HRT; Attia’s framing bridges the GSM/UTI use case with the broader menopausal-aging estrogen discussion. (novelty: 3)
- 2026-07-20 — Theca cells: active orchestrators of ovarian aging.: cross-connection with senolytics: Review frames theca-cell senescence as an upstream cause of estrogen biosynthesis failure, linking senolytic rescue of the theca compartment to the endogenous-estrogen deficit that HRT addresses downstream. (novelty: 3)
- 2026-08-05 — Hepatic SIRT6 Deficiency Accelerates Female-Specific Aging Through SULT1E1-Mediated Estrogen Depletion.: cross-connection with sirt6-activators: Hepatic SIRT6/SULT1E1 control of estrogen sulfation offers an endogenous, non-HRT lever on female estrogen decline, connecting SIRT6 pharmacology to menopausal aging biology. (novelty: 3)
- 2026-08-17 — Ovarian aging and systemic health: Mechanisms and emerging intervention strategies.: cross-connection with senolytics: Review positions ovary-targeted senolytics and estrogen replacement as complementary arms of ovarian-aging intervention — senolytics addressing SASP-driven inflammaging at the source, HRT compensating for downstream estrogen decline. (novelty: 3)
- 2026-06-26 — Hormonal dimorphism in sarcopenia disease.: cross-connection with apelin: Review ties apelin decline to menopausal estrogen loss, connecting the apelin sarcopenia hypothesis to HRT considerations. (novelty: 3)
- 2026-04-02 — Ginsenoside Rg1 enhances stem cell abundance in aging human skeletal muscle after resistance exercise.: cross-connection with ginsenosides: Rg1 blunted exercise-induced estradiol depletion and raised progesterone in postmenopausal women, connecting ginsenoside pharmacology to sex-steroid dynamics relevant to menopausal aging. (novelty: 3)
- 2026-06-29 — Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration.: Geroscience review (Nov 2024) reframes abrupt female sex-hormone decline at menopause as a primary, sex-specific upstream driver of aging alongside genomic/mtDNA damage and telomere attrition, arguing HRT belongs in multi-target prevention rather than symptom relief alone — conceptual argument, no new outcome data. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Mechanistic redundancy and hierarchy of aging mechanisms: implications for strategies to extend healthspan and biomarker integration.
29-jun-2026
novelty 3
per-area 3
strengthens